Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model.
暂无分享,去创建一个
Jorma Hinkula | Gabriel P Krestin | Thijs Kuiken | T. Kuiken | A. Osterhaus | G. Krestin | G. van Amerongen | L. D. de Waal | M. Dijkshoorn | K. Stittelaar | Albert D M E Osterhaus | Geert van Amerongen | J. Hinkula | Leon de Waal | Marcel L Dijkshoorn | Koert J Stittelaar | Edwin J B Veldhuis Kroeze | Vera J Teeuwsen | V. Teeuwsen | E. Veldhuis Kroeze
[1] R. Compans,et al. Virus-Like Particle Vaccine Containing Hemagglutinin Confers Protection against 2009 H1N1 Pandemic Influenza , 2011, Clinical and Vaccine Immunology.
[2] T. Kuiken,et al. Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets. , 2011, Vaccine.
[3] A. Osterhaus,et al. Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets. , 2011, Vaccine.
[4] T. Kuiken,et al. Immunization of Macaques with Formalin-Inactivated Respiratory Syncytial Virus (RSV) Induces Interleukin-13-Associated Hypersensitivity to Subsequent RSV Infection , 2002, Journal of Virology.
[5] Xiufan Liu,et al. Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. , 2011, Vaccine.
[6] G. Kärber,et al. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[7] M. Kieny,et al. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. , 2011, Vaccine.
[8] T. Kuiken,et al. Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. , 2011, The American journal of pathology.
[9] C. Black. Systematic review of the biology and medical management of respiratory syncytial virus infection. , 2003, Respiratory care.
[10] D. Weiner,et al. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. , 2011, Vaccine.
[11] Thomas P. Fabrizio,et al. Contemporary Seasonal Influenza A (H1N1) Virus Infection Primes for a More Robust Response To Split Inactivated Pandemic Influenza A (H1N1) Virus Vaccination in Ferrets , 2010, Clinical and Vaccine Immunology.
[12] R. Rappuoli,et al. Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization , 2009, Science Translational Medicine.
[13] Ron A M Fouchier,et al. Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus , 2010, The Journal of infectious diseases.
[14] T. Kuiken,et al. Pulmonary pathology of pandemic influenza A/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography , 2011, The Journal of general virology.
[15] Hideo Goto,et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.
[16] C. J. Martel,et al. CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets , 2011, PloS one.
[17] K. Subbarao,et al. Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets. , 2011, The Journal of infectious diseases.
[18] M. Salazar,et al. Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. , 2011, Vaccine.
[19] T. Tumpey,et al. Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets. , 2011, Vaccine.
[20] Marion Koopmans,et al. Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.